These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3217275)

  • 21. Expression of transforming growth factor-beta 1 in prostate cancer.
    Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
    Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of fos and sis proto-oncogenes and genes of the extracellular matrix proteins during butyrate induced glioma differentiation.
    Tang SJ; Ko LW; Lee YH; Wang FF
    Biochim Biophys Acta; 1990 Jan; 1048(1):59-65. PubMed ID: 2105102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates.
    Lau HL; Zhu XM; Leung PC; Chan LW; Chen GF; Chan PS; Yu KL; Chan FL
    Int J Oncol; 2001 Dec; 19(6):1193-201. PubMed ID: 11713589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
    Björk P; Isaacs JT; Hartley-Asp B
    Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular visualization of prostate cancer using magnetic resonance imaging.
    Heckl S; Pipkorn R; Waldeck W; Spring H; Jenne J; von der Lieth CW; Corban-Wilhelm H; Debus J; Braun K
    Cancer Res; 2003 Aug; 63(16):4766-72. PubMed ID: 12941791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated Ki-ras oncogene in human prostatic adenocarcinoma.
    Peehl DM; Wehner N; Stamey TA
    Prostate; 1987; 10(4):281-9. PubMed ID: 3601807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
    Sikes RA; Chung LW
    Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.
    Hawksworth D; Ravindranath L; Chen Y; Furusato B; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):311-5. PubMed ID: 20820186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of mRNA and protein levels of beta1 integrin variants in human prostate carcinoma.
    Perlino E; Lovecchio M; Vacca RA; Fornaro M; Moro L; Ditonno P; Battaglia M; Selvaggi FP; Mastropasqua MG; Bufo P; Languino LR
    Am J Pathol; 2000 Nov; 157(5):1727-34. PubMed ID: 11073831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia.
    Fleming WH; Hamel A; MacDonald R; Ramsey E; Pettigrew NM; Johnston B; Dodd JG; Matusik RJ
    Cancer Res; 1986 Mar; 46(3):1535-8. PubMed ID: 2417706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proto-oncogene expression in dermal naevi and melanomas.
    Peris K; Cerroni L; Chimenti S; Soyer HP; Kerl H; Höfler H
    Arch Dermatol Res; 1991; 283(8):500-5. PubMed ID: 1686168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
    Pääkkö P; Nuorva K; Kamel D; Soini Y
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell.
    Segal NH; Cohen RJ; Haffejee Z; Savage N
    Arch Pathol Lab Med; 1994 Jun; 118(6):616-8. PubMed ID: 8204007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic methylation patterns of the Dunning R-3327 prostate adenocarcinoma system.
    Blount LV; Cooke DB
    Cancer Lett; 1996 Jan; 98(2):213-8. PubMed ID: 8556711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.
    Untawale S; Blick M
    Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actin filament organization of the Dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential.
    Zachary JM; Cleveland G; Kwock L; Lawrence T; Weissman RM; Nabell L; Fried FA; Staab EV; Risinger MA; Lin S
    Cancer Res; 1986 Feb; 46(2):926-32. PubMed ID: 3940653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.